Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross margin | 88.8% | 89.4% | 89.3% | 89.4% | 89.3% | 87.7% | 87.8% | 88.0% | 87.0% | 88.3% | 90.2% | 95.3% | 95.5% | 93.9% | 87.8% | 91.9% | 92.7% | 92.7% | 92.4% | 88.9% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Gross margin is 88.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for United Therapeutics Corporation have been 91.2% over the past three years, and 96.1% over the past five years.
As of today, United Therapeutics Corporation's Gross margin is 88.9%, which is higher than industry median of 65.9%. It indicates that United Therapeutics Corporation's Gross margin is Good.